Skip to content

Veeva Summit showcases AI and data innovations advancing agentic commercial

Veeva Summit showcases AI and data innovations advancing agentic commercial
Photo by Nick Karvounis / Unsplash

Veeva Systems has announced that leaders from AstraZeneca, Bristol Myers Squibb, Grünenthal, Novo, Roche, and UCB are among those who will share strategies for driving commercial and medical excellence at Veeva Commercial Summit, Europe, 18–19 November in Copenhagen, Denmark.

Attendees will hear how industry-specific AI is enabling sales, marketing, and medical teams to improve customer engagement, uncover valuable insights, and accelerate compliant content delivery. Veeva will showcase how field and digital interactions can become Commercial Evidence, helping biopharmas better understand HCP and patient needs and improve treatment outcomes.

As one of Europe's largest gatherings of life sciences leaders, Veeva Commercial Summit brings together 1,200+ industry experts. More than 100 sessions will highlight customer success and AI innovations with Commercial Cloud and Data Cloud, including:

Unlocking new capabilities with Agentic Commercial

  • Grünenthal and Roche scaling agentic customer engagement to deliver connected HCP journeys across field, digital, and events
  • GSK and other leading biopharmas enabling a more intelligent, personalized HCP experience with agentic CRM
  • BeOne Medicines using insights from conversational AI on brand sites to identify and address treatment barriers for HCPs and patients
  • Bristol Myers Squibb speeding promotional content approvals and increasing productivity with agentic MLR

Building the data foundation for AI

  • AstraZeneca leveraging HCP access data to improve field targeting for sales growth
  • Bayer and Servier building a trusted global data foundation to scale AI and enable better decision-making across markets

Delivering greater medical impact to improve patient outcomes

  • Biogen, UCB, and another leading biopharma turning medical insights into action to improve decision-making and patient outcomes
  • Bayer, Novo, and One MSL exploring how rising HCP use of AI is reshaping scientific engagement strategies

“The pace of innovation across life sciences is accelerating, with AI creating new opportunities for more meaningful, timely engagement with HCPs and patients,” said Chris Moore, president of Veeva Europe. “Veeva Summit brings together a community of leaders to share learnings and ideas as the industry advances toward an Agentic Commercial model.”

The event is open exclusively to life sciences professionals, who can register at veeva.com/eu/Summit.

Sign up to our newsletter

The week's biggest stories from this industry, direct to your inbox.

Personal information

More in Robotics & Automation

See all

More from Olivia Friett

See all